Vyant Bio (VYNT) executive Roberts bought 14,481 shares for $50.1K at an average $3.46
Insider transactions reported
John A Roberts (executive at Vyant Bio Inc., VYNT) reported that they bought 14,481 shares for $50.1K at an average $3.46 between May 24, 2021 and May 26, 2021. After these transactions the filing shows 312,117 shares held directly.
- Reporting person
- Roberts John A
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 24, 2021 | Open-market purchase (P) | Common Stock, $0.0001 par value | +7,440 | $3.38 | $25.1K | 305,076 direct |
| May 26, 2021 | Open-market purchase (P) | Common Stock, $0.0001 par value | +7,041 | $3.55 | $25K | 312,117 direct |
Holdings before and after
- Common Stock, $0.0001 par value: 297,636 to 312,117 direct
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Roberts report in this VYNT Form 4?
John A Roberts (executive at Vyant Bio Inc., VYNT) reported that they bought 14,481 shares for $50.1K at an average $3.46 between May 24, 2021 and May 26, 2021. After these transactions the filing shows 312,117 shares held directly.
How many VYNT shares does Roberts hold after this filing?
The filing shows 312,117 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for VYNT
Earlier insider filings at VYNT
- May 21, 2021SEC Form 4: Yeh Yung-Ping bought $3,290 worth of Common Stock (1,000 units at $3.29), increasing direct ownership by 0.08% to 1,329,602 units
- May 21, 2021SEC Form 4: LaFrence Andrew D.C. bought $9,837 worth of Common Stock (3,000 units at $3.28), increasing direct ownership by 10% to 32,336 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow VYNT and get a push notification the moment its next story breaks.